Birdwatch Note Rating
2024-05-01 05:05:00 UTC - HELPFUL
Rated by Participant: 18DFBB7C7D15BDA66CD9C16B1B5AF5CFEF337C1F2CADBC05A640468DBF1FAC0B
Participant Details
Original Note:
EBC-46 is a compound with potential anti-cancer properties that has been successfully used in veterinary medicine and is currently being studied for use in humans. However, the claim of it killing cancer in 48 hours should be viewed in the context of ongoing research. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182759/ https://www.europeanpharmaceuticalreview.com/news/175005/novel-cancer-therapeutic-synthesised-by-stanford-researchers/
All Note Details